Back to results

Dominican University of California

Best Practices in a Clinical Development Project Management Office (PMO) to Achieve a Reference Standard in the Pharmaceutical Industry

Abstract

dc:description.abstract

<p>Medications are developed by the pharmaceutical industry starting with the discovery phase, proceeds to preclinical trials, moves into clinical trials (progressing from Phase I to Phase III), and if the data are positive, may lead to Food and Drug Administration (FDA) approval. Once approved, post-marketing surveillance for safety is required as long as the drug is marketed to consumers. This phase may also include clinical trial Phase IV studies if additional safety testing is required. This process usually takes between ten to fifteen years, with clinical development taking seven to ten years of that time <a>(1)</a>. Clinical development can be facilitated by a clinical development Project Management Office (PMO) at pharmaceutical companies. Clinical development PMOs provide value by establishing processes that can be universally adopted by the pharmaceutical industry. This can help simplify product development, and as a result, accelerate time to market. Clinical development project management is a relatively new field in the pharmaceutical industry, and there are few publications and literary reviews regarding standardized best practices, current best practices, and potential best practices for clinical development.</p> <p>Decreasing the time it takes a drug to reach market can help patients live longer and/or improve their quality of life. Time to market is often driven by the time it takes to test the product in clinical settings. This thesis is focused on analyzing the clinical development project management practices in order to reduce the time to market. The goals of this project were to identify best practices in clinical development project management, compile a reference standard, develop a rubric, evaluate the rubric on a comparator company, and make a recommendation regarding actions required for the comparator company to achieve the reference standard.</p>

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
Master's Thesis
Discipline thesis:degree_discipline
Biological Sciences
Year dc:date.available
2018

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Guinto, Russell
Contributors dc:contributor
  • Kathryn Davidson, MA, MS
  • Maggie Louie, PhD

Subjects

dc:subject × 8

Identifiers

dc:identifier.*
Repository record dc:identifier
https://scholar.dominican.edu/masters-theses/354
OAI identifier oai:identifier
oai:scholar.dominican.edu:masters-theses-1366

Chain of custody

source
Harvested from
Dominican University of California
Base URL
scholar.dominican.edu/do/oai/
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Guinto, Russell. Best Practices in a Clinical Development Project Management Office (PMO) to Achieve a Reference Standard in the Pharmaceutical Industry. Master's Thesis thesis, 2018. https://scholar.dominican.edu/masters-theses/354